<?xml version="1.0" encoding="UTF-8"?>
<!-- This sitemap was dynamically generated on April 3, 2026 at 11:37 pm by All in One SEO v4.9.5.1 - the original SEO plugin for WordPress. -->

<?xml-stylesheet type="text/xsl" href="https://eularis.com/default-sitemap.xsl"?>

<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
	<channel>
		<title>Eularis</title>
		<link><![CDATA[https://eularis.com]]></link>
		<description><![CDATA[Eularis]]></description>
		<lastBuildDate><![CDATA[Wed, 12 Aug 2020 14:58:21 +0000]]></lastBuildDate>
		<docs>https://validator.w3.org/feed/docs/rss2.html</docs>
		<atom:link href="https://eularis.com/sitemap.rss" rel="self" type="application/rss+xml" />
		<ttl><![CDATA[60]]></ttl>

		<item>
			<guid><![CDATA[https://eularis.com/blog/]]></guid>
			<link><![CDATA[https://eularis.com/blog/]]></link>
			<title>Blog</title>
			<pubDate><![CDATA[Wed, 12 Aug 2020 14:58:21 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://eularis.com/why-your-pharma-ai-strategy-is-probably-broken-and-what-a-real-blueprint-looks-like/]]></guid>
			<link><![CDATA[https://eularis.com/why-your-pharma-ai-strategy-is-probably-broken-and-what-a-real-blueprint-looks-like/]]></link>
			<title>Why Your Pharma AI Strategy Is Probably Broken— And What a Real Blueprint Looks Like</title>
			<pubDate><![CDATA[Wed, 25 Feb 2026 10:47:41 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://eularis.com/the-hidden-cost-of-having-no-ai-strategy-spoiler-its-not-what-you-think/]]></guid>
			<link><![CDATA[https://eularis.com/the-hidden-cost-of-having-no-ai-strategy-spoiler-its-not-what-you-think/]]></link>
			<title>The Hidden Cost of Having No AI Strategy (Spoiler: It&#8217;s Not What You Think)</title>
			<pubDate><![CDATA[Tue, 31 Mar 2026 09:02:12 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://eularis.com/course_landing_pages/complete-training-in-ai-for-pharma-execs/]]></guid>
			<link><![CDATA[https://eularis.com/course_landing_pages/complete-training-in-ai-for-pharma-execs/]]></link>
			<title>Complete Training in AI for Pharma Execs (On-line training)</title>
			<pubDate><![CDATA[Tue, 24 Mar 2026 14:54:50 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://eularis.com/ai-training-in-pharma/]]></guid>
			<link><![CDATA[https://eularis.com/ai-training-in-pharma/]]></link>
			<title>Training</title>
			<pubDate><![CDATA[Tue, 24 Mar 2026 13:26:41 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://eularis.com/ai-end-to-end-implementation/]]></guid>
			<link><![CDATA[https://eularis.com/ai-end-to-end-implementation/]]></link>
			<title>AI end to end implementation</title>
			<pubDate><![CDATA[Tue, 24 Mar 2026 12:35:10 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://eularis.com/ai-training-for-pharma/]]></guid>
			<link><![CDATA[https://eularis.com/ai-training-for-pharma/]]></link>
			<title>AI training for pharma</title>
			<pubDate><![CDATA[Thu, 26 Mar 2026 10:50:22 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://eularis.com/membership/]]></guid>
			<link><![CDATA[https://eularis.com/membership/]]></link>
			<title>Training AI in Pharma Main Page [DEMO]</title>
			<pubDate><![CDATA[Thu, 26 Mar 2026 10:39:01 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://eularis.com/about/]]></guid>
			<link><![CDATA[https://eularis.com/about/]]></link>
			<title>About</title>
			<pubDate><![CDATA[Thu, 26 Mar 2026 10:08:10 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://eularis.com/cro-2-0-transforming-tomorrows-clinical-research-process-with-artificial-intelligence/]]></guid>
			<link><![CDATA[https://eularis.com/cro-2-0-transforming-tomorrows-clinical-research-process-with-artificial-intelligence/]]></link>
			<title>CRO 2.0: Transforming Tomorrow&#8217;s Clinical Research Process with Artificial Intelligence</title>
			<pubDate><![CDATA[Thu, 26 Mar 2026 09:34:10 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://eularis.com/are-llms-already-on-their-way-to-being-obsolete/]]></guid>
			<link><![CDATA[https://eularis.com/are-llms-already-on-their-way-to-being-obsolete/]]></link>
			<title>Are LLMs Already On Their Way to Being Obsolete?</title>
			<pubDate><![CDATA[Thu, 26 Mar 2026 09:33:34 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://eularis.com/ai-strategy-ai-advisory-ai-competency-programs-pharma/]]></guid>
			<link><![CDATA[https://eularis.com/ai-strategy-ai-advisory-ai-competency-programs-pharma/]]></link>
			<title>AI Strategy, Advisory and Competency Programs Pharma</title>
			<pubDate><![CDATA[Sat, 28 Mar 2026 10:53:16 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://eularis.com/services-2/]]></guid>
			<link><![CDATA[https://eularis.com/services-2/]]></link>
			<title>Services</title>
			<pubDate><![CDATA[Sat, 28 Mar 2026 10:34:00 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://eularis.com/wishlist-member/]]></guid>
			<link><![CDATA[https://eularis.com/wishlist-member/]]></link>
			<title>WishList Member</title>
			<pubDate><![CDATA[Mon, 30 Mar 2026 20:47:24 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://eularis.com/resources/factory-maintenance-automation-with-an-ai-agent/]]></guid>
			<link><![CDATA[https://eularis.com/resources/factory-maintenance-automation-with-an-ai-agent/]]></link>
			<title>Factory maintenance automation with an AI Agent</title>
			<pubDate><![CDATA[Sat, 21 Mar 2026 16:22:15 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://eularis.com/the-ai-strategy-blind-spot-why-technical-excellence-isnt-enough/]]></guid>
			<link><![CDATA[https://eularis.com/the-ai-strategy-blind-spot-why-technical-excellence-isnt-enough/]]></link>
			<title>The AI Strategy Blind Spot: Why Technical Excellence Isn&#8217;t Enough</title>
			<pubDate><![CDATA[Tue, 27 Jan 2026 09:00:01 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://eularis.com/]]></guid>
			<link><![CDATA[https://eularis.com/]]></link>
			<title>Home</title>
			<pubDate><![CDATA[Sat, 28 Mar 2026 10:32:33 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://eularis.com/ai-strategic-blueprint-for-pharma/]]></guid>
			<link><![CDATA[https://eularis.com/ai-strategic-blueprint-for-pharma/]]></link>
			<title>AI Strategic Blueprint for Pharma</title>
			<pubDate><![CDATA[Mon, 23 Mar 2026 14:24:02 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://eularis.com/how-to-overcome-ai-resistance-in-your-organization/]]></guid>
			<link><![CDATA[https://eularis.com/how-to-overcome-ai-resistance-in-your-organization/]]></link>
			<title>How to Overcome AI Resistance in Your Organization</title>
			<pubDate><![CDATA[Tue, 20 Jan 2026 09:00:01 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://eularis.com/competing-and-winning-using-ai-in-healthcare/]]></guid>
			<link><![CDATA[https://eularis.com/competing-and-winning-using-ai-in-healthcare/]]></link>
			<title>Competing and Winning Using AI in Healthcare</title>
			<pubDate><![CDATA[Tue, 17 Feb 2026 09:00:32 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://eularis.com/ai-and-diversity-inclusion-building-equitable-technology-for-all/]]></guid>
			<link><![CDATA[https://eularis.com/ai-and-diversity-inclusion-building-equitable-technology-for-all/]]></link>
			<title>AI and Diversity &amp; Inclusion: Building Equitable Technology for All</title>
			<pubDate><![CDATA[Tue, 16 Dec 2025 09:16:47 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://eularis.com/the-future-of-ai-and-innovation-in-pharma-in-2026-and-beyond/]]></guid>
			<link><![CDATA[https://eularis.com/the-future-of-ai-and-innovation-in-pharma-in-2026-and-beyond/]]></link>
			<title>The Future of AI and Innovation in Pharma in 2026 and Beyond</title>
			<pubDate><![CDATA[Tue, 13 Jan 2026 09:00:30 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://eularis.com/ai-powered-transformation-in-pharma-regulatory-affairs/]]></guid>
			<link><![CDATA[https://eularis.com/ai-powered-transformation-in-pharma-regulatory-affairs/]]></link>
			<title>AI-Powered Transformation in Pharma Regulatory Affairs</title>
			<pubDate><![CDATA[Tue, 10 Feb 2026 09:00:59 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://eularis.com/pharmacovigilence-4-0-transforming-data-into-decisions-with-ai/]]></guid>
			<link><![CDATA[https://eularis.com/pharmacovigilence-4-0-transforming-data-into-decisions-with-ai/]]></link>
			<title>PharmacoVigilence 4.0: Transforming Data into Decisions with AI</title>
			<pubDate><![CDATA[Tue, 06 Jan 2026 09:00:06 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://eularis.com/why-companies-that-wait-for-ai-to-mature-are-falling-behind/]]></guid>
			<link><![CDATA[https://eularis.com/why-companies-that-wait-for-ai-to-mature-are-falling-behind/]]></link>
			<title>Why Companies That Wait for AI to Mature Are Falling Behind</title>
			<pubDate><![CDATA[Tue, 03 Feb 2026 09:00:17 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://eularis.com/case-studies/how-ai-reversed-a-3-8b-patent-cliff-crisis/]]></guid>
			<link><![CDATA[https://eularis.com/case-studies/how-ai-reversed-a-3-8b-patent-cliff-crisis/]]></link>
			<title>How AI Reversed a $3.8B Patent Cliff Crisis</title>
			<pubDate><![CDATA[Thu, 15 Jan 2026 17:52:58 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://eularis.com/resources/automated-change-requests-in-regulatory-dossiers-using-llms-and-nlp/]]></guid>
			<link><![CDATA[https://eularis.com/resources/automated-change-requests-in-regulatory-dossiers-using-llms-and-nlp/]]></link>
			<title>Automated change requests in regulatory dossiers using LLMs and NLP</title>
			<pubDate><![CDATA[Thu, 05 Feb 2026 19:10:39 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://eularis.com/why-embedding-artificial-intelligence-is-critical-for-successful-digital-marketing/]]></guid>
			<link><![CDATA[https://eularis.com/why-embedding-artificial-intelligence-is-critical-for-successful-digital-marketing/]]></link>
			<title>Why Embedding Artificial Intelligence is Critical for Successful Digital Marketing</title>
			<pubDate><![CDATA[Tue, 25 Nov 2025 09:00:09 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://eularis.com/how-pharma-companies-can-build-trustworthy-ai-agents/]]></guid>
			<link><![CDATA[https://eularis.com/how-pharma-companies-can-build-trustworthy-ai-agents/]]></link>
			<title>How Pharma Companies Can Build Trustworthy AI Agents</title>
			<pubDate><![CDATA[Tue, 09 Dec 2025 09:00:47 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://eularis.com/when-your-board-asks-whats-our-ai-strategy-the-case-for-outside-perspective/]]></guid>
			<link><![CDATA[https://eularis.com/when-your-board-asks-whats-our-ai-strategy-the-case-for-outside-perspective/]]></link>
			<title>When Your Board Asks &#8216;What&#8217;s Our AI Strategy?&#8217; &#8211; The Case for Outside Perspective</title>
			<pubDate><![CDATA[Tue, 21 Oct 2025 08:00:19 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://eularis.com/navigating-pharmas-budget-cuts-strategies-for-innovators/]]></guid>
			<link><![CDATA[https://eularis.com/navigating-pharmas-budget-cuts-strategies-for-innovators/]]></link>
			<title>Navigating Pharma Budget Cuts: Innovation Is The Key</title>
			<pubDate><![CDATA[Tue, 11 Nov 2025 09:00:15 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://eularis.com/the-regulatory-paradox-vibe-coding-medical-tools-in-a-compliance-heavy-industry/]]></guid>
			<link><![CDATA[https://eularis.com/the-regulatory-paradox-vibe-coding-medical-tools-in-a-compliance-heavy-industry/]]></link>
			<title>The Regulatory Paradox: Vibe Coding Medical Tools in a Compliance-Heavy Industry</title>
			<pubDate><![CDATA[Tue, 02 Dec 2025 09:00:54 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://eularis.com/case-studies/ai-for-reshaping-content-across-channels-formats-uses-and-predicting-most-impactful-variants/]]></guid>
			<link><![CDATA[https://eularis.com/case-studies/ai-for-reshaping-content-across-channels-formats-uses-and-predicting-most-impactful-variants/]]></link>
			<title>AI for Reshaping content across channels/formats/uses and predicting most impactful variants</title>
			<pubDate><![CDATA[Thu, 09 Oct 2025 15:32:13 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://eularis.com/ai-fireside-chat-life-sciences-research-development/]]></guid>
			<link><![CDATA[https://eularis.com/ai-fireside-chat-life-sciences-research-development/]]></link>
			<title>AI Fireside Chat &#8211; Life Sciences Research &amp; Development</title>
			<pubDate><![CDATA[Sun, 05 Oct 2025 12:36:08 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://eularis.com/ai-fireside-chat-life-sciences-research-development-video/]]></guid>
			<link><![CDATA[https://eularis.com/ai-fireside-chat-life-sciences-research-development-video/]]></link>
			<title>AI Fireside Chat &#8211; Life Sciences Research &amp; Development &#8211; Video</title>
			<pubDate><![CDATA[Mon, 06 Oct 2025 16:24:06 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://eularis.com/digital-therapeutics-when-ai-becomes-the-treatment/]]></guid>
			<link><![CDATA[https://eularis.com/digital-therapeutics-when-ai-becomes-the-treatment/]]></link>
			<title>Digital Therapeutics: When AI Becomes the Treatment</title>
			<pubDate><![CDATA[Tue, 04 Nov 2025 09:00:07 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://eularis.com/how-to-embed-ai-into-healthcare-market-research-for-greater-results/]]></guid>
			<link><![CDATA[https://eularis.com/how-to-embed-ai-into-healthcare-market-research-for-greater-results/]]></link>
			<title>How to Embed AI into Healthcare Market Research for Greater Results</title>
			<pubDate><![CDATA[Tue, 28 Oct 2025 09:00:15 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://eularis.com/pharmas-tough-pill-to-swallow-the-pressing-need-for-next-gen-business-models-and-transformation-using-ai/]]></guid>
			<link><![CDATA[https://eularis.com/pharmas-tough-pill-to-swallow-the-pressing-need-for-next-gen-business-models-and-transformation-using-ai/]]></link>
			<title>Pharma&#8217;s tough pill to swallow: the pressing need for next-gen business models and transformation using AI</title>
			<pubDate><![CDATA[Tue, 14 Oct 2025 08:00:51 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://eularis.com/balancing-privacy-and-personalisation-in-modern-pharmaceutical-marketing/]]></guid>
			<link><![CDATA[https://eularis.com/balancing-privacy-and-personalisation-in-modern-pharmaceutical-marketing/]]></link>
			<title>Balancing Privacy and Personalisation in Modern Pharmaceutical Marketing</title>
			<pubDate><![CDATA[Tue, 30 Sep 2025 08:00:32 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://eularis.com/leadership-redefined-thriving-alongside-intelligent-machines/]]></guid>
			<link><![CDATA[https://eularis.com/leadership-redefined-thriving-alongside-intelligent-machines/]]></link>
			<title>Leadership Redefined: Thriving Alongside Intelligent Machines</title>
			<pubDate><![CDATA[Tue, 18 Nov 2025 09:00:00 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://eularis.com/how-pharma-and-medical-devices-are-leveraging-augmented-reality-ar/]]></guid>
			<link><![CDATA[https://eularis.com/how-pharma-and-medical-devices-are-leveraging-augmented-reality-ar/]]></link>
			<title>How Pharma &amp; Medical Devices Leverage Augmented Reality</title>
			<pubDate><![CDATA[Tue, 16 Sep 2025 08:00:20 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://eularis.com/virtual-patients-how-ai-simulation-is-reducing-drug-development-costs/]]></guid>
			<link><![CDATA[https://eularis.com/virtual-patients-how-ai-simulation-is-reducing-drug-development-costs/]]></link>
			<title>Virtual Patients: How AI Simulation is Reducing Drug Development Costs</title>
			<pubDate><![CDATA[Tue, 09 Sep 2025 08:00:07 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://eularis.com/the-ai-race-to-cure-rare-diseases-small-markets-big-data-solutions/]]></guid>
			<link><![CDATA[https://eularis.com/the-ai-race-to-cure-rare-diseases-small-markets-big-data-solutions/]]></link>
			<title>The AI Race to Cure Rare Diseases: Small Markets, Big Data Solutions</title>
			<pubDate><![CDATA[Tue, 07 Oct 2025 08:00:57 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://eularis.com/resources/ai-to-pressure-test-strategy/]]></guid>
			<link><![CDATA[https://eularis.com/resources/ai-to-pressure-test-strategy/]]></link>
			<title>AI to pressure test strategy</title>
			<pubDate><![CDATA[Thu, 11 Sep 2025 14:23:34 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://eularis.com/ai-training-in-pharma-and-life-sciences-australia/]]></guid>
			<link><![CDATA[https://eularis.com/ai-training-in-pharma-and-life-sciences-australia/]]></link>
			<title>AI training in pharma and life sciences Australia</title>
			<pubDate><![CDATA[Fri, 24 Oct 2025 10:23:41 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://eularis.com/is-ais-putting-pressure-on-pharma-agency-dynamics/]]></guid>
			<link><![CDATA[https://eularis.com/is-ais-putting-pressure-on-pharma-agency-dynamics/]]></link>
			<title>Is AI&#8217;s Putting Pressure On Pharma &amp; Agency Dynamics?</title>
			<pubDate><![CDATA[Fri, 15 Aug 2025 09:16:02 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://eularis.com/build-versus-buy-for-pharmaceutical-ai-should-i-build-or-should-i-buy/]]></guid>
			<link><![CDATA[https://eularis.com/build-versus-buy-for-pharmaceutical-ai-should-i-build-or-should-i-buy/]]></link>
			<title>Build versus Buy for Pharmaceutical AI: Should I Build or Should I Buy?</title>
			<pubDate><![CDATA[Fri, 15 Aug 2025 08:30:14 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://eularis.com/resources/using-ai-to-understand-policy-makers-incentives-and-make-recommendations-to-align-incentives-with-them/]]></guid>
			<link><![CDATA[https://eularis.com/resources/using-ai-to-understand-policy-makers-incentives-and-make-recommendations-to-align-incentives-with-them/]]></link>
			<title>Using AI to understand policy makers incentives and make recommendations to align incentives with them</title>
			<pubDate><![CDATA[Tue, 12 Aug 2025 16:35:57 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://eularis.com/future-pharmas-secret-weapon-the-ai-augmented-sales-rep/]]></guid>
			<link><![CDATA[https://eularis.com/future-pharmas-secret-weapon-the-ai-augmented-sales-rep/]]></link>
			<title>Future Pharma’s Secret Weapon: The AI-Augmented Sales Rep</title>
			<pubDate><![CDATA[Tue, 02 Sep 2025 08:00:04 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://eularis.com/services-2/ai-speaking-engagements/]]></guid>
			<link><![CDATA[https://eularis.com/services-2/ai-speaking-engagements/]]></link>
			<title>AI Speaking Engagements</title>
			<pubDate><![CDATA[Fri, 24 Oct 2025 11:09:00 +0000]]></pubDate>
		</item>
				</channel>
</rss>
